Zynerba Pharmaceuticals (ZYNE) P/FCF US GAAP (year values) |
||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | |||
| P/FCF | -1.39 | -3.80 | -2.14 | -3.37 | 0.00 | -2.05 | ||
| Changes by years, y/y, % | +173% | -44% | +58% | -100% | ||||
Zynerba Pharmaceuticals. P/FCF
Zynerba Pharmaceuticals. P/FCF, changes, %
Zynerba Pharmaceuticals (ZYNE) P/FCF US GAAP (quarter values) |
||||||||
| FY2022Q2 | FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | LTM ? | |||
| P/FCF | -1.84 | -1.26 | 0.00 | -0.67 | -0.51 | -2.05 | ||
| Changes by years, y/y, % | -69% | -76% | -100% | -80% | -72% | |||
| Changes by quarters, q/q, % | -44% | -31% | -100% | -23% | ||||